News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
752,729 Results
Type
Article (53726)
Company Profile (325)
Press Release (698678)
Section
Business (217907)
Career Advice (2873)
Deals (37655)
Drug Delivery (118)
Drug Development (86580)
Employer Resources (182)
FDA (17200)
Job Trends (16102)
News (370271)
Policy (36016)
Tag
Academia (2889)
Alliances (53364)
Alzheimer's disease (1407)
Approvals (17158)
Artificial intelligence (228)
Bankruptcy (384)
Best Places to Work (12224)
Biotechnology (214)
Breast cancer (239)
Cancer (1817)
Cardiovascular disease (143)
Career advice (2408)
CAR-T (132)
Cell therapy (386)
Clinical research (69508)
Collaboration (706)
Compensation (375)
COVID-19 (2778)
C-suite (173)
Data (1665)
Diabetes (226)
Diagnostics (6647)
Earnings (88443)
Employer resources (158)
Events (119133)
Executive appointments (598)
FDA (18138)
Funding (630)
Gene therapy (278)
GLP-1 (746)
Government (4827)
Healthcare (20082)
Infectious disease (2897)
Inflammatory bowel disease (132)
Interviews (553)
IPO (17057)
Job creations (4338)
Job search strategy (1993)
Layoffs (496)
Legal (8941)
Lung cancer (274)
Manufacturing (255)
Medical device (13919)
Medtech (13924)
Mergers & acquisitions (20962)
Metabolic disorders (608)
Neuroscience (1856)
NextGen: Class of 2025 (7154)
Non-profit (4890)
Northern California (2127)
Obesity (340)
Opinion (245)
Patents (172)
People (62050)
Phase I (21543)
Phase II (30477)
Phase III (22837)
Pipeline (734)
Postmarket research (2968)
Preclinical (9194)
Radiopharmaceuticals (253)
Rare diseases (353)
Real estate (6571)
Regulatory (24108)
Research institute (2565)
Resumes & cover letters (454)
Southern California (1825)
Startups (3914)
United States (19085)
Vaccines (691)
Weight loss (250)
Date
Today (51)
Last 7 days (624)
Last 30 days (2757)
Last 365 days (36001)
2025 (4669)
2024 (36830)
2023 (41759)
2022 (52990)
2021 (57662)
2020 (56539)
2019 (49830)
2018 (37750)
2017 (34745)
2016 (34731)
2015 (40774)
2014 (34887)
2013 (30238)
2012 (32233)
2011 (32858)
2010 (31059)
Location
Africa (943)
Arizona (225)
Asia (43630)
Australia (7717)
California (4875)
Canada (1739)
China (413)
Colorado (223)
Connecticut (236)
Europe (95460)
Florida (700)
Georgia (168)
Illinois (497)
Indiana (273)
Maryland (778)
Massachusetts (3734)
Michigan (204)
Minnesota (352)
New Jersey (1382)
New York (1386)
North Carolina (911)
Northern California (2127)
Ohio (176)
Pennsylvania (1116)
South America (1326)
Southern California (1825)
Texas (719)
Utah (147)
Washington State (489)
752,729 Results for "forum pharmaceuticals formerly known as envivo pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CNS Pharmaceuticals to Present at the 18th Annual European Life Sciences CEO Forum
February 20, 2025
·
2 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Genetown
Corbus Pharmaceuticals to Participate in the BTIG Obesity Health Forum
Corbus Pharmaceuticals Holdings, Inc. today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will participate in a panel discussion as part of the BTIG Obesity Health Forum, to be held virtually on May 8, 2024.
May 1, 2024
·
3 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Dr. Jonathan Javitt and Dr. David Feifel to Present Keynote Address, Beyond Ketamine Monotherapy: Combined Interventional Treatment of Suicidal Depression and PTSD, at the 8th Annual Neuroscience Innovation Forum in San Francisco
January 7, 2025
·
8 min read
Press Releases
Rapafusyn Pharmaceuticals to Showcase Its Molecular Glue Drug Discovery Platform at WuXi Global Forum
January 9, 2025
·
1 min read
Genetown
Deciphera Pharmaceuticals to Present at the Stifel 2024 Virtual Targeted Oncology Forum
Deciphera Pharmaceuticals, Inc. today announced that members of the management team will participate in a fireside chat at the Stifel 2024 Virtual Targeted Oncology Forum on Tuesday, April 16, 2024 at 11:30 AM ET.
April 9, 2024
·
1 min read
Business
A Conversation with Peter Marks and Tom Whitehead: Insights into GenScript Biotech Forum 2025 (Teaser)
In this short teaser, BioSpace’s Head of Insights Lori Ellis talks to CBER Director Peter Marks and Tom Whitehead, Co-Founder of the Emily Whitehead Foundation about anticipated discussions at the upcoming GenScript Biotech Forum.
January 10, 2025
·
1 min read
·
Lori Ellis
Biotech Beach
MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum
MEI Pharma, Inc. (Nasdaq: MEIP), a clinical-stage pharmaceutical company evaluating novel drug candidates to address known resistance mechanisms to standard-of-care cancer therapies, today announced that David Urso, president and chief executive officer of MEI Pharma, will participate in a fireside chat at the Stifel 2024 Virtual Targeted Oncology Forum on Tuesday, April 16 at 1:30 PM Eastern Time.
April 10, 2024
·
3 min read
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Marinus Pharmaceuticals Lays Off 45% of Employees
The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.
November 14, 2024
·
1 min read
·
Angela Gabriel
1 of 75,273
Next
